Tranexamic acid

Generic Name
Tranexamic acid
Brand Names
Cyklokapron, Lysteda
Drug Type
Small Molecule
Chemical Formula
C8H15NO2
CAS Number
1197-18-8
Unique Ingredient Identifier
6T84R30KC1
Background

Tranexamic acid is a synthetic derivative of lysine used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.

It was first patented in 1957 and received its initial US approval in 1986.

Indication

Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema, cyclic heavy menstrual bleeding in premenopausal females, and other instances of significant bleeding in the context of hyperfibrinolysis. Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleed...

Associated Conditions
Bleeding, Heavy Menstrual Bleeding, Hereditary Angioedema (HAE)
Associated Therapies
-

Single Dose Enteral Tranexamic Acid in Critically Ill Patients

First Posted Date
2012-09-12
Last Posted Date
2015-11-17
Lead Sponsor
San Diego Veterans Healthcare System
Target Recruit Count
4
Registration Number
NCT01683747
Locations
🇺🇸

VA San Diego Health Care System, San Diego, California, United States

Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

First Posted Date
2012-09-12
Last Posted Date
2023-04-03
Lead Sponsor
Henry Ford Health System
Target Recruit Count
139
Registration Number
NCT01683955
Locations
🇺🇸

Henry Ford Hospital, Detroit, Michigan, United States

🇺🇸

HFH Main campus, Detroit, Michigan, United States

Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding

First Posted Date
2012-08-07
Last Posted Date
2015-02-16
Lead Sponsor
Kay I Waud MD PhD
Target Recruit Count
100
Registration Number
NCT01659008
Locations
🇺🇸

Sentara Norfolk General Emergency Department, Norfolk, Virginia, United States

🇺🇸

Jones Institue Clinical Research Center, Norfolk, Virginia, United States

Haemorrhage Alleviation With Tranexamic Acid- Intestinal System

First Posted Date
2012-08-06
Last Posted Date
2020-04-17
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
12009
Registration Number
NCT01658124
Locations
🇬🇧

Over 50 countries Worldwide, London, United Kingdom

Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery

First Posted Date
2012-08-02
Last Posted Date
2012-10-16
Lead Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Target Recruit Count
118
Registration Number
NCT01655641
Locations
🇳🇵

Tribhuvan University Teaching Hospital, Kathmandu, Kathmandy, Nepal

Efficacy of Tranexamic Acid in Brain Tumor Resections

First Posted Date
2012-08-02
Last Posted Date
2012-08-02
Lead Sponsor
Colombian Foundation for Epilepsy and Neurological Disease
Target Recruit Count
100
Registration Number
NCT01655927
Locations
🇨🇴

Colombian foundation center for epilepsy and neurological disease, Cartagena, Bolivar, Colombia

Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection

First Posted Date
2012-07-26
Last Posted Date
2015-09-18
Lead Sponsor
Sunnybrook Health Sciences Centre
Target Recruit Count
24
Registration Number
NCT01651182
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Reduction Bleeding in Laminectomy With Double Doses of Tranexamic Acid

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-07-18
Last Posted Date
2013-12-18
Lead Sponsor
Mahidol University
Target Recruit Count
78
Registration Number
NCT01643135
Locations
🇹🇭

Manee Raksakietisak, Bangkok, Thailand

The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach

First Posted Date
2012-06-19
Last Posted Date
2020-11-05
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
80
Registration Number
NCT01622946
Locations
🇧🇪

UZ Pellenberg, Pellenberg, Belgium

Reducing Post Operative Bleeding Following Cabg

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2012-05-17
Last Posted Date
2012-05-18
Lead Sponsor
University of Malaya
Target Recruit Count
40
Registration Number
NCT01600599
Locations
🇲🇾

Pusat Perubatan University Malaya, Petaling Jaya, Selangor, Malaysia

© Copyright 2024. All Rights Reserved by MedPath